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Fibrinolysis in Cutaneous Vasculitis
The term 'cutaneous vasculitis' describes a group of disorders in which a salient feature is inflammation of the dermal blood vessels; this group is confusing not only in clinical classification but also in etiology and pathogenesis. There is evidence that in some patients immunological mechanisms may be responsible for the onset (Cochrane 1968 , Katz et al. 1968 ); whatever the precipitating factor, changes occur in the microcirculation which may even lead to vascular occlusion.
It therefore seemed reasonable to investigate coagulation and fibrinolytic mechanisms in patients with cutaneous vasculitis. This review reports the findings of investigations on blood and skin fibrinolytic activity carried out in such patients.
Seventy cases of cutaneous vasculitis were investigated, the main varieties being necrotizing vasculitis, purpuric vasculitis, erythema nodosum and erythema multiforme (Cunliffe & Menon 1971) . The blood fibrinolytic activity was measured by a modification (Menon 1967 ) of von Kaulla's method (1963) , and the results were compared with matched controls.
In 29 cases (41 Y.) blood fibrinolytic activity was reduced; the abnormal result was repeated and a consistent abnormality obtained in 24 patients. A significant relationship was also found between the activity of the disease and fibrinolytic activity in that, in the 8 patients so investigated, the abnormal result returned to normal when the lesions regressed.
Data on the relationship between vasculitis and blood fibrinolysis is conflicting. Isacson (1970) has found similar abnormalities, but Turner & Ryan (1969) and Vaithiainathan & Takats (1968) have found no such relationship.
The reduced fibrinolysis in our cases was probably not a primary process, both because the patients investigated were a heterogeneous group and because reduced blood fibrinolysis may also occur in other thrombotic lesions such as coronary infarction (Chakrabarti et al. 1968 ). It was important to correlate the blood findings with fibrinolytic activity of the skin. Using Turner & Ryan's modification (1969) of Todd's technique (1959) we investigated tissue fibrinolysis in 13 patients. A marked decrease in skin fibrinolysis was found in the lesions, compared to control skin; lysis in section in skin affected by vasculitis was 2-1 %, compared to 27 % in normal skin. We also have some preliminary evidence that clinically normal skin near the lesions also has reduced fibrinolysis. We suggest that in the development of the vasculitis lesions certain enzymes concerned with fibrinolysis, perhaps plasminogen activator, become incorporated in the thrombus or coat the vessel wall; alternatively, there may be an increase of fibrinolytic inibitors locally in the lesions or released into the blood.
Whatever the mechanism, we wondered whether we could improve the clinical condition by increasing the blood fibrinolytic activity. An open study on 12 patients using the fibrinolytic drugs phenformin and ethyloestrenol (Fearnley & Chakrabarti 1964 ) for a minimum of six months resulted in an improvement in 8 cases. Two patients, one with an extensive necrotizing vasculitis and one with Behoet's syndrome who had thrombosis in the skin vessels and deep leg veins, have improved dramatically with treatment during the past four years.
It therefore appears that patients with cutaneous vasculitis have abnormal fibrinolytic mechanisms and these findings open up possible therapeutic advances.
[For a fuller report of this research see Cunliffe & Menon 1971 , Cunliffe et al. 1971 
